Skip to main content
大禹生物 logo

大禹生物 — Investor Relations & Filings

Ticker · 920970 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 384 across all filing types
Latest filing 2026-04-26 Audit Report / Informat…
Country CN China
Listing Beijing Stock Exchange 920970

About 大禹生物

http://www.sxdysw.cn/

Shanxi Dayu Biological Assistance Co., Ltd. specializes in the research, development, and production of advanced animal nutrition and health solutions. The company focuses on the manufacturing of feed additives, micro-ecological preparations, and biological feed products. Its core portfolio includes probiotics, enzyme preparations, and functional premixes designed to enhance livestock immunity, improve feed conversion rates, and promote sustainable farming practices. By leveraging biotechnology, the firm provides integrated solutions for the aquaculture and animal husbandry sectors, emphasizing scientific innovation and product quality to support the modernization of the agricultural supply chain.

Recent filings

Filing Released Lang Actions
2025年度审计报告
Audit Report / Information Classification · 100% confidence The document is titled as an "审计报告" (Audit Report) for the fiscal year 2025 of 山西大禹生物工程股份有限公司. It contains detailed audit opinions, basis for audit opinions, key audit matters, responsibilities of management and auditors, and signatures of certified public accountants. It also includes comprehensive financial statements such as consolidated and parent company balance sheets, income statements, and cash flow statements with detailed notes. The presence of an independent auditor's report with audit opinions and detailed financial data confirms this is a standalone audit report rather than a full annual report or other filing. The document length is substantial (15,000 characters), and it contains actual financial data and audit details, not just an announcement or certification. Therefore, the document fits the category of Audit Report / Information (AR). FY 2025
2026-04-26 Chinese
2025年年度报告摘要
Annual Report Classification · 95% confidence The document is titled '年度报告摘要' which translates to 'Annual Report Summary' for the year 2025. It contains detailed financial data including assets, liabilities, net profit, earnings per share, shareholder structure, and other comprehensive company information. It also includes auditor's opinion and management assurances about the report's accuracy. The length is over 5,000 characters and it is not merely an announcement or a certification. The content matches the characteristics of a full Annual Report, providing a comprehensive overview of the company's financial performance and business activities for the fiscal year. Therefore, the document should be classified as an Annual Report (10-K). FY 2025
2026-04-26 Chinese
第四届董事会第九次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 9th meeting of the 4th Board of Directors of Shanxi Dayu Biological Engineering Co., Ltd. It includes multiple agenda items such as approval of the 2025 Annual Report, 2026 Q1 Report, audit reports, internal control reports, financial budget, remuneration plans, and other governance-related reports. The document references various reports that have been or will be disclosed on the Beijing Stock Exchange information platform, indicating that this document itself is a board meeting resolution announcement rather than the reports themselves. The document is not the full annual report or audit report but a board meeting announcement of decisions and approvals related to these reports and other governance matters. Therefore, it fits best under the category of Board/Management Information (MANG).
2026-04-26 Chinese
2026年一季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2026年第一季度报告" which translates to "2026 First Quarter Report." It contains detailed financial data including consolidated and parent company balance sheets, profit and loss statements, cash flow statements, and notes on financial data changes. The report covers the period from January to March 2026, indicating it is a quarterly financial report. The document explicitly states it is unaudited and includes management's responsibility statements. The length is substantial (15,000 characters), and it contains actual financial statements and analysis, not just an announcement or certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q1 2026
2026-04-26 Chinese
2025年度独立董事述职报告（宋晓敏已离任）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director's Annual Report" for the year 2025 by an independent director who has left the company. It details the director's duties, attendance, communication with auditors, supervision of internal controls, and involvement in governance matters during the year. It includes no financial statements or substantive financial data but focuses on the director's role, activities, and compliance with regulations. The document is a report on board/management information specifically about the independent director's annual duties and resignation. It is not an annual report, audit report, or any financial report. Therefore, the best fitting category is Board/Management Information (MANG). The document length is 4097 characters, which is sufficient for a detailed report rather than a brief announcement or certification. Confidence is high due to clear content and context.
2026-04-26 Chinese
关于2026年度董事、高级管理人员薪酬方案的公告
Remuneration Information Classification · 95% confidence The document is an announcement regarding the 2026 remuneration scheme for the company's directors and senior management. It details the salary structure, performance pay, and incentive plans for non-independent directors, independent directors, and senior management. It also describes the approval process and conditions under which remuneration may be reduced or withheld. The document is not a full annual report, audit report, or financial statement, but rather a disclosure about executive compensation policies. This fits the definition of Remuneration Information (DEF 14A), which covers reports detailing compensation for top executives and directors.
2026-04-26 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.